The mission of the Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center –Faculty of Medicine (AUBMC FM) is to reduce the burden of cancer in Lebanon and the region through the application of state-of-the-art medical knowledge and technology and the development of integrated and advanced programs in patient care, research, education and prevention.
The vision of the Naef K. Basile Cancer Institute (NKBCI) is to be a leading institute for cancer prevention and treatment through promoting excellence in patient care, research, and education and enhancing effectiveness and collaboration among cancer programs and healthcare providers.
The Naef K. Basile Cancer Institute (NKBCI) at the American University of Beirut Medical Center (AUBMC) became operational in 2007 upon receiving a generous contribution by the Naef K. Basile Foundation. The foundation was first established in 1995 following the death of Dr. Naef Basile, a Lebanese-American obstetrician-gynecologist whose lifelong wish was to give back to his country of birth through founding a cutting-edge cancer institute that would compare to the best cancer centers in the world.
- Department of Radiation Therapy
- Division of Hematology Oncology
The Daniel ACC will feature an expansion of the chemotherapy ambulatory treatment unit to include 42 beds. This expansion will allow the accommodation of more patients in a timely and effective manner. With more subspecialized faculty joining the Naef K. Basile Cancer Institute at AUBMC, the number of clinics will increase to accommodate more patients without delay especially that cancer patients are all urgent. The flow of patients at the Daniel ACC will be based on patient-centered care where the patient will be assessed by all concerned health professionals. A centralized phlebotomy lab and oncology pharmacy dedicated for our patients is another service of excellence provided at Daniel ACC.